Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma

Am J Hematol. 2019 May;94(5):E143-E146. doi: 10.1002/ajh.25438. Epub 2019 Mar 6.

¹ Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
² Laboratory of Hematoimmunology, Department of Clinical Laboratory Sciences, School of Health Sciences, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.
³ Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
⁴ Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan.
⁵ Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
⁶ Hematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
⁷ Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
⁸ Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
⁹ Hematology, Osaka City University Hospital, Osaka, Japan.
¹⁰ Department of Hematology, Oita University Hospital, Yufu, Japan.
¹¹ Department of Hematology, Heart-Life Hospital, Okinawa, Japan.
¹² Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
¹³ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
¹⁴ Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
¹⁵ Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.

No abstract available

Publication types